Living With Gorlin Syndrome: Patient Experience, Burden, Advocacy, and Care

Conclusions

• Gorlin syndrome is a highly variable lifelong disorder that often causes delayed diagnosis because its many manifestations can appear across multiple organ systems and at different ages.
• The greatest disease burdens are recurrent basal cell carcinomas and jaw cysts, but the syndrome can also cause serious neurologic, skeletal, ocular, and gynecologic complications.
• Earlier recognition matters because diagnostic delays can expose patients to unnecessary procedures and potentially harmful ionizing radiation, which should be minimized or avoided whenever possible.
• Patients need coordinated, lifelong, multidisciplinary surveillance rather than episodic care, with specialists involved according to age, sex, and organ involvement.
• There is no single curative or Gorlin-specific FDA-approved treatment, so current management relies on repeated procedures, preventive care, and individualized treatment selection.
• Some common treatments can reduce lesion burden, but repeated interventions also create significant scarring, pain, and cumulative physical and emotional harm.
• Radiation therapy is particularly dangerous in Gorlin syndrome and can worsen or trigger basal cell carcinomas, making it contraindicated for these patients.
• Family experiences show that children and adults with Gorlin syndrome can still lead active lives, but they require ongoing monitoring and timely treatment to avoid preventable progression.
• Patient education, peer support, and compassionate communication are essential because hidden burdens and psychosocial impacts are substantial and often underestimated.
• Advocacy organizations can meaningfully improve care by providing education, linking patients to experts, supporting research, and driving the development of better treatments and future FDA-approved therapies.